SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Board Changes

18 Feb 2022 07:00

RNS Number : 0610C
McBride PLC
18 February 2022
Β 

18 February 2022

Β 

McBride plc

Β 

Board Changes

Β 

McBride plc ("McBride" or the "Company") announces the appointment of Regi Aalstad as a Non-Executive Director with effect from 14 March 2022.

Β 

Regi has extensive leadership experience in global fast moving consumer goods. She has held Regional General Manager and Vice President positions with Procter & Gamble in Europe, Asia, Middle East and Africa. Regi is a Non-Executive Director at Ontex Group NV and in several tech start-ups. She also works as an advisor to Private Equity and to global strategy consultancies. Regi holds a Master of Business Administration from the University of Michigan, USA.

Β 

She previously held Non-Executive Director positions at Telenor ASA, and Geberit AG and was the Chair of an international NGO.

Β 

Regi will serve as a member of the Nomination, Remuneration and Audit & Risk Committees. Regi's appointment satisfies the requirements of Provision 24 of the UK Corporate Governance Code.

Β 

Steve Hannam, Senior Independent Non-executive Director, having served nine years, will be stepping down from the Board immediately following the annual general meeting on 18th October 2022. Succession planning for his role as Senior Independent Director is underway and at the end of this process we should be in a position to release further information regarding the appointment of a new Senior Independent Director.

Β 

Jeff Nodland, Chairman of McBride commented:

Β 

"Regi brings extensive experience from the global fast moving consumer goods market. Her knowledge of the Asian and European markets, along with her strong board experience will be extremely beneficial to the Board. We are delighted to welcome Regi to McBride.

Β 

I would like to take the opportunity to thank Steve for his wise counsel and guidance over the last nine years. Steve's insight and contribution to Board discussions have been invaluable to the Board and the business, from which we will continue to benefit until the AGM. I wish him the very best for the future."

Β 

McBride has been notified that there are no further details to be disclosed in respect of Regi Aalstad pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority and this announcement is made in accordance with Listing Rule 9.6.11.

Β 

Β 

Β 

McBride plc

Β 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

Β 

Β 

Β 

FTI Consulting

Β 

Ed Bridges, Nick Hasell

020 3727 1000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFITFVIDLIF
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.